Handling Market Dips: A Little Advice from a Wall Street Insider

Подписаться 917

50% 1

In this video, we'll explore the recent turbulence affecting small-cap stocks, particularly in the biotech sector. Dylan will share essential strategies to maintain your composure amidst market chaos. Drawing from his early experiences on Wall Street and advice from mentors, Dylan explains why it's crucial not to "pee on the rug at the first sound of thunder."
You'll learn about the importance of investing in solid businesses and not panicking at the first sign of trouble. If you're feeling uncertain about your investments, this video provides practical advice and encouragement.
Please hit like, subscribe, and share if you find these insights helpful. Remember to stay calm and resilient, because steady wins the race!
✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼
/ @behindthemarkets
✅ VISIT OUR WEBSITE 👇🏼👇🏼
behindthemarkets.com/

Опубликовано:

18 апр 2024

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист

Посмотреть позже

Комментарии : 4

@myhalowithin 3 месяца назад

Big person 'thunder-ware' advice! Love it! 😁 and, timely. Blessings to you and yours, Dylan. 💫

@behindthemarkets 3 месяца назад

Thank you so much ❤

@judis3850 3 месяца назад

I was in the business for over 20 years. I started in 1993. I went through many bear markets, big market dips, and what I always did was buy then. I always saw them as stocks going on sale. This one's a little different. It's so choppy I don't know what to make of it. And I'm hesitant to buy anything during this dip. I'm not panicking and selling anything, I've been down this road too many times so I know better. But I do wish I could feel more comfortable so I could do some buying. As it is, this market has me stymied. And I've never felt that before. Lol I guess there's a first time for everything!

@behindthemarkets 3 месяца назад

Yeah, this market is a bit twitchy. The FED is fighting against lots of fiscal spending. Add to that the election, and it does feel strange. Reminds me of the "Goldilocks" debate in 2005 and in 2015-2016. But the biotech sector has sold off, which makes firms like IOVA look very compelling to me.